73554-8

Abciximab induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)

Active

Part Description

LP171382-7 Abciximab
Abciximab is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.

Many of the side effects of abciximab are due to its anti-platelet effects. This includes an increased risk of bleeding. The most common type of bleeding due to abciximab is gastrointestinal hemorrhage.

Thrombocytopenia is a rare but known serious risk. Abciximab-induced thrombocytopenia can typically be treated with transfusion of platelets. Abciximab induced thrombocytopenia can last for seven days after initial drug administration. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Abciximab

Fully-Specified Name

Component: Abciximab induced platelet Ab.IgM
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: Flow cytometry

Additional Names

Short Name: Abciximab ind plt IgM SerPl Ql FC
Display Name: Abciximab induced platelet IgM FC Ql
Consumer Name Alpha Get Info: Abciximab induced platelet IgM, Blood

Example Answer List: LL360-9

Source: Regenstrief Institute

Answer	Code	Score	Answer ID
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value)			LA6576-8
NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value)			LA6577-6

Basic Attributes

Class: SERO
Type: Laboratory
First Released: Version 2.44
Last Updated: Version 2.66
Change Reason: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation: Both

Member of these Panels

LOINC	Long Common Name
72908-7	Drug induced platelet Ab panel - Serum or Plasma

Language Variants Get Info

Tag	Language	Translation
es-ES	Spanish (Spain)	Abciximab Acs. IgM plaquetario inducido:PrThr:Punto temporal:Suero o Plasma:Ord:Citometria de flujo (FC)
es-MX	Spanish (Mexico)	Abciximab plaquetario inducido Ab.IgM:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Citometría de flujo (FC)
fr-FR	French (France)	Plaquettes anticorps IgM induits par abciximab:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Cytométrie de flux
it-IT	Italian (Italy)	Abciximab Ab.IgM piastrine indotti da:PrThr:Pt:Siero/Plasma:Ord:Citometria a flusso Synonyms: Anticorpi IgM anticorpo Citometria a flusso (FC) Piastrine Plasma Presenza o Soglia Punto nel tempo (episodio) Siero Siero o Plasma Sierologia (anticorpi e la maggior parte degli ant
nl-NL	Dutch (Netherlands)	abciximab geïnduceerd trombocyt As.IgM:aanwezigheid:moment:serum of plasma:ordinaal:flowcytometrie Synonyms: antistof; antilichaam
pt-BR	Portuguese (Brazil)	Abciximab plaquetas induzida Ac.IgM::Pt:Soro/Plas:Ord:Citometria de fluxo
ru-RU	Russian (Russian Federation)	Абциксимаб индуцированный пластинка Ат.IgM:PrThr:ТчкВрм:Сыв/Плаз:Пор:Проточная цитометрия Synonyms: Антитело индуцированные к пластинкам Ат Плазма Порядковый Сыворотка Сыворотка или Плазма Точка во времени;Момент Тромбоцит
tr-TR	Turkish (Turkey)	Abciximab uyarılmış trombosit Ab.IgM:MevcEşik:Zmlı:Ser/Plaz:Srl:Akış sitometri Synonyms: Ak Ak.IgM Akış hücremetresi Mevcut
zh-CN	Chinese (China)	阿昔单抗诱导型血小板抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:流式细胞测量术 Synonyms: Ab.IgM;IgM;抗体 IgM Ab;自身抗体依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫球蛋白 M 动态存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）循环型抗体可见于血清当中。循环型血小板 Ab 循环型血小板抗体时刻;随机;随意;瞬间流流式细胞光度计;流式细胞测量术（Flow Cytometry，FC）;流式细胞计游离型血小板 Ab 游离型血小板抗体血小板 Ab 血小板 Ab IgM 血小板 Ab.IgM 血小板 Ab.游离型血小板 IgM 血小板抗体 IgM 血小板抗体.游离型血小板自身 Ab 血小板自身抗体血栓细胞血清;血清学;血清学检验项目;血清学检验项目 (非微生物学);血清学检验项目（非微生物学）;血清学检验项目类;血清学检验项目类 (非微生物学);血清学类;血清学类检验项目;血清学类检验项目 (非微生物学);血清学类试验;血清学类试验 (非微生物学);血清学试验;血清学试验 (非微生物学);血清学试验（非微生物学）;血清学试验类 (非微生物学);血清类血清或血浆诱导型（诱导性、诱发型）血小板抗体诱导型（诱导性、诱发型）血小板抗体.IgM 阿西单抗;阿昔;阿西;Abciximab;platelet glycoprotein Ⅱb/Ⅲa receptor inhibitor;血小板表面糖蛋白受体 (GPⅡb/Ⅲa)拮抗剂;血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂;血小板糖蛋白Iib/IIIa受体拮抗剂;血小板糖蛋白Ⅱb/Ⅲa受体抑制剂;ReoPro;阿昔单克隆抗体

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=73554-8

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.